MH Services

1. What is the current average and 90th percentile waiting time for ADHD post diagnostic therapies (including psychotherapies), broken down by (a) NHS providers and (b) outsourced private providers?

2. What is the current average and 90th percentile waiting time for ASD post diagnostic therapies (including psychotherapies), broken down by (a) NHS providers and (b) outsourced private providers?

3. How many ADHD referral requests were (a) declined and (b) deemed ‘not clinically urgent’ by NHS services in the last 12 months?

4. How many ASD referral requests were (a) declined and (b) deemed ‘not clinically urgent’ by NHS services in the last 12 months?

5. What percentage of patients diagnosed with ADHD by the NHS receive (a) medication titration and (b) follow-up care within 3 months?

6. Are any post-diagnosis services outsourced to private providers? Which?

7. What is the current waitlist time for dementia assessment?

8. What is the split by demographics (under 60 vs over 60)?

9. Which providers are you working with to support on memory assessments (eg. dementia)?
Please can you share the spend broken down by provider for FY24/25
Please can you share the spend broken down by provider for FY23/24

10. What other mental conditions does the NHS use private providers to deliver assessments for?

11. Which providers are you working with for these assessments?
Please provide a breakdown of all NCA spend by category across mental health services for FY24/25
Please provide a breakdown of all NCA spend by category across mental health services for FY23/24

I am writing to request information under the Freedom of Information Act 2000. Please could you provide the following information in relation to your ICB’s commissioning of ADHD and Autism services:
Commissioning Contacts
1. The name(s) of the person or people responsible for commissioning ADHD assessment and diagnosis services.
2. The name(s) of the person or people responsible for commissioning Autism assessment and diagnosis services.
3. The telephone number(s) for the above contacts (ADHD and Autism commissioning).
4. The email address(es) for the above contacts (ADHD and Autism commissioning).
If personal details cannot be provided due to GDPR, please supply a team or departmental contact instead.
Waiting Lists
5. The current size of the ADHD assessment waiting list for adults.
6. The current size of the ADHD titration waiting list for CAMHS.
7. The current size of the Autism assessment waiting list (please specify if this is for adults, children, or both).
Referral Volumes
8. The average number of ADHD referrals for adults received per month over the past 12 months.
9. The average number of ADHD referrals for CAMHS received per month over the past 12 months.
10. The average number of Autism referrals received per month over the past 12 months.
Private Sector Support
11. Do you currently utilise any private provider support to manage ADHD referrals?
If yes, please provide:
• Name of the provider
• Contract start and end date
• Annual contract value (£GBP)
12. Do you currently utilise any private sector support to manage Autism referrals?
If yes, please provide:
• Name of the provider
• Contract start and end date
• Annual contract value (£GBP)

I am writing to request information under the Freedom of Information Act 2000.
Please could you provide the following information:
1. The total number of new diagnoses of Parkinson’s disease recorded by your Trust/Health Board for each of the past four calendar years (2022,2023,2024,2025).
2. If available, a breakdown of these figures by:
a. Age groups (e.g. under 50, 50–59, 60–69, 70–79, 80+)
b. Gender e.g. Male, Female

I am currently completing a Master’s in Digital Operations and Improvement, with a focus on data. Given my role and the area, I work in, I have decided to focus my data piece on Mental Health Inpatient Readmissions. To build my dataset, I am placing a Freedom of Information Request to all NHS Mental Health Inpatient Services.

I kindly ask if you could provide responses to the following questions:

1. Do you collect data on the readmission rates of patients who have been admitted to an inpatient facility for a mental health condition at your Trust?
2. If you do, how many patients were readmitted for inpatient mental health care, including out-of-area admissions:
– Three months after they were discharged.
– Six months after they were discharged.
– Twelve months after they were discharged.
3. At what intervals do you follow up with patients after they are discharged from secondary mental health care? Tick all that apply:
– 1 week
– Within 1 month
– Between 1 and 3 months
– 3 to 6 months
– 12 months
4. In the last 12 months (May 2024 to May 2025), how many patients who required secondary mental health services were discharged from your Trust to Primary Care?
5. How many people detained under the Mental Health Act (MHA) were discharged to primary care?
6. How many patients were admitted to hospital following care by the Crisis Resolution Home Treatment Team/Home-based Treatment Team after:
– 3 months
– 6 months
– 12 months
7. What has been the average length of stay over the last five years in adult acute mental health care at your Trust, including those patients sent out of area?

Please could you provide the following performance data for the IAPT/NHS Talking Therapies service covering following years:
2021 to 2024 inclusive and 2025 YTD, broken down annually and monthly as appropriate
1. Average waiting time for patients from referral to assessment
appointment in weeks
2. Average waiting time for patients after the assessment
appointment to the start of treatment in weeks
3. Total number of patients on waiting list by month
4. The reliable recovery rate % by month
5. How many total patients are in contact with the service (Referrals, Assessment, Treatment etc)
6. Names of the providers operating the IAPT/NHS Talking Therapies
Counselling services during the periods
requested
7. Any contract warnings or breach notices issued to the provider
due to performance failures/failure to meet KPIs 8. How many FTE Staff are employed in the Talking Therapies service?
9. How many Vacant FTE roles are there within the Talking Therapies Service?
10. Number of referrals received each month?

I am writing to submit a request under the Freedom of Information Act 2000 as part of my PhD research investigating the mental health and social harms related to cannabis and cocaine use within the UK healthcare system.
Please provide anonymized, aggregate data for the period from 1 January 2000 to 31 December 2024 covering the following areas:
1. Mental Health Service Users
o Number of individuals accessing psychiatric services related to cannabis and cocaine use.
o Number of individuals receiving counselling or psychotherapy (including CBT, psychodynamic therapy, and other modalities) for mental health conditions linked to cannabis and cocaine use.
o Age, gender, and geographical breakdowns of these service users where available.
2. Treatment Episodes and Modalities
o Total number of treatment episodes delivered for cannabis and cocaine-related mental health conditions, including inpatient, outpatient, community, and day services.
o Types of psychiatric and psychological interventions provided (e.g., medication management, counselling, psychotherapy, group therapy).
3. Outcomes and Follow-Up
o Available data on treatment outcomes (e.g., completion rates, relapse rates) and follow-up or readmission rates for cannabis and cocaine-related cases.
4. Referral Sources and Waiting Times
o Main referral pathways for cannabis and cocaine-related mental health services (e.g., GP, self-referral, criminal justice system, hospital).
o Average waiting times from referral to first appointment for psychiatric, counselling, or psychotherapy services linked to cannabis and cocaine use.
5. Co-occurring Conditions
o Proportion of service users presenting with co-occurring mental health and substance use disorders.
o Data on co-use of other substances where available.
While I am particularly interested in data coded under ICD-10 codes F12 (mental and behavioural disorders due to cannabinoids) and F14 (due to cocaine), I request that you also include any relevant data on mental health conditions, treatments, service usage, and outcomes related to cannabis and cocaine use, regardless of coding systems or classifications used within your trust.
Please also can you provide details of any other clinical / internal codes used to classify or record such cases and treatments.
If some of the requested data is not held in exactly the format specified, please provide data in the closest available format or inform me of any limitations.

I would be grateful if you could please answer the following question.

In the last 12 months, how many unique patients have been treated for Insomnia (ICD-10 code G47.0) with the following products:

1). Zopiclone
2). Zolpidem
3). Any other Melatonin product

If you cannot provide the information for each product, please provide the information that you do have available.

1.What is the name of your Trust?

2. Where are you based?
England
Scotland
Wales
Northern Ireland

3. Do you run an adult ADHD service?
Yes
No (If No the form will skip everything until Q13)

4. How many adults are currently waiting for an ADHD assessment across your Trust?
Please enter the total number. If you do not record this information please enter: Not recorded

5. How many referrals for adult ADHD assessments did you receive across your trust in 2024?
Please enter the total number. If you do not record this information please enter: Not recorded

6.How many adult ADHD assessments did you carry out across your trust in 2024?
Please enter the total number. If you do not record this information please enter: Not recorded

7.Do you support patients while they are on the waiting list?
Yes
No (If No the form will skip Q8)

8.Please outline what support you offer patients while they are on the waiting list?

9.Has your any part of your Trust closed waiting lists for new adult ADHD assessment referrals at any point in the last 12 months?
Yes
No (If No the form will skip Q10)

10. Please give details of which services were affected and for how long?

11.Do any adult ADHD services across your trust have an exclusion criteria for assessment referrals?
Yes
No (If no, the form will skip Q12)

12.Please select all relevant reasons from this list:
We do not accept patients over a certain age
We only accept patients with complex cases, eg other mental health conditions
We do not accept patients who are being seen by an adult mental health team or have complex mental health conditions
We do not accept patients if we believe their symptoms are not causing significant functional impairment
The service is only commissioned to see a certain amount of patients, so new referrals are rejected after that target is reached

13.Feel free to add any more information here

I am currently looking into the available evidence on behaviours of headbanging and non-anchored ligatures within adult inpatient mental health settings.

As part of this review, I am keen to include information on policies, procedures, areas of good practice that may have been developed. Is there anything within your setting that is shareable?

I am writing to request information under the Freedom of Information Act 2000.

Please provide the following information for the time period between 1st January 2019 (or the date of inception for your trust) and 5th May 2025, inclusive.

1. Please send me a copy of any documents outlining guidelines or codes of conduct regarding mental health care plans which have been used or disseminated within the Trust. This should include any materials relating to NICE, CPA Policy, and ‘Triangle of Care’.

2. Please send me a copy of any documents outlining guidelines or codes of conduct regarding care coordinators which have been used or disseminated within the Trust. This should include any materials relating to NICE and ‘Triangle of Care’.

3. Please send me copies of all Serious and Untoward Incident Review documents which relate to the treatment of mental health patients within your trust.

1. How many peer workers/peer mentors or similar roles does your Trust employ?
2. How many senior peer worker/peer supervisor/peer development worker or similar roles does
your Trust employ?
3. What band(s) are your senior peer worker (or similarly titled) roles?
4. Can you provide a job description for these roles?
5. Who supervises the senior peer workers in your Trust
6. Does your Trust employ a lived experience lead/peer support lead?
7. If so, what band(s) are they recruited to?
8. Can you provide a job description for your peer support lead (or similarly titled) role(s)?
9. Did you receive any allocations via the NHSE Mental Health Programme grant funding over the
last 4 years?
10. How many peer workers and peer supervisors (or similarly titled roles) have you trained through
the NHSE training grant funding route?
11. How did the grant money help your organisation?

I am writing to request information under the Freedom of Information Act 2000. I would be grateful if you could provide the following information.

1. The number of individual patients treated in your trust who are diagnosed, either as a primary diagnosis or a co-morbid diagnosis, with the following mental health conditions/available categorisation over the past five years/available time period:

– Psychosis / Schizophrenia / Schizo-Affective Disorder
– Treatment Resistant Depression
– Bipolar / Cyclothymia / Hypomania
– Eating Disorders
– EUPD/CEN
– Other
– Diagnosis not recorded

2. The total number of admissions in your trust involving the following mental health conditions/available categorisation, where individuals have been sectioned under the Mental Health Act over the past five years/available time period:

– Psychosis / Schizophrenia / Schizo-Affective Disorder
– Treatment Resistant Depression
– Bipolar / Cyclothymia / Hypomania
– Eating Disorders
– EUPD/CEN
– Other
– Diagnosis not recorded

3. Does your trust have a specialist care pathway, such as EIP (Early Intervention in Psychosis), that provides treatment for the following conditions:

– Bipolar/Cyclothymia/Hypomania
– Psychosis/Schizophrenia/Schizo-Affective Disorder
– EUPD/CEN
– Treatment resistent depression
– Eating Disorders

4. If ‘yes’, please describe these care pathways.

5. If ‘yes’, please provide the estimated annual spend for said specialist care pathways for each year / available time period, providing the name of each service, from 2019 to 2025.

I would like to know a bit about the dementia diagnosis pathways at your organisation. I have detailed my request in the attached letter.

FOI Request – Diagnosis of Alzheimer’s Disease
1. I would be grateful if you could send the Trust’s most recent planning document(s) for the diagnosis and treatment of Alzheimer’s Disease including implementation of lumbar punctures (CSF) and Blood-based Biomarker testing. Please include planning documents that cover the entire Trust and specific department plans, such as neurology, psychiatry, care of the elderly, pathology or memory clinic teams.

2. How many patients were diagnosed with Alzheimer’s Disease (ICD-10 codes = G30, G30.1, G30.8, G30.9, F00, F00.1, F00.2 or F00.9) in your Trust in the last 12-month period for which data are available?
3. How many patients were diagnosed with Mild Cognitive Impairment and / or Mild Dementia due to Alzheimer’s Disease (ICD-10 codes = G31.84, G30.1, or MMSE scores = 21 to 24) in your Trust in the last 12-month period for which data are available?
4. Where, if at all, does the Trust carry out lumbar punctures (cerebrospinal fluid) for diagnosing patients with Alzheimer’s Disease?
5. Please provide a list of the full names of other Trusts or other organisations to which the Trust refers patients for lumbar punctures in the diagnosis of Alzheimer’s Disease.
6. What is the average waiting time for a patient to get an appointment for a lumbar puncture to test for a diagnosis of Alzheimer’s Disease?
7. How many lumbar punctures to test for Alzheimer’s Disease took place in the last 3-month period for which data are available?
8. How many Blood-based Biomarker (BBBM) tests from Cerebrospinal fluid (CSF) to test for Alzheimer’s Disease were conducted in the last 3-month period for which data are available?
9. Where, if at all, does the Trust carry out Blood-based Biomarker (BBBM) tests from Cerebrospinal fluid (CSF) for diagnosing patients with Alzheimer’s Disease?
10. Please provide a list of the full names of other Trusts or other organisations, to which the Trust refers Blood-based Biomarker tests from cerebrospinal fluid (CSF) for pathology in the diagnosis of Alzheimer’s Disease.
11. What is the average waiting time for pathology results to come back from Blood-based Biomarker tests?
12. To what extent are there plans for service improvement of diagnosing Alzheimer’s Disease?
13. Are the plans for service improvement of diagnosing Alzheimer’s Disease related to:
Cognitive assessment services
Biomarker services
None / neither
14. Which of the following services does the Trust have in place in preparation for increased service delivery for Alzheimer’s Disease? Please complete the table provided.

This is a freedom of information request.

Section A

(A1) Does your organisation commission Adult ADHD Assessments? If yes, please list:
(A1-i) the organisation or organisations in receipt of commission from you alongside the contract value for the last public sector financial year (1st April 2024 – 31st March 2025) and the current public sector financial year (1st April 2025 – 31st March 2026).

(A2)Does your organisation commission Child ADHD Assessments? If yes, please list:
(A2-i) the organisation or organisations in receipt of commission from you alongside the contract value for the last public sector financial year (1st April 2024 – 31st March 2025) and the current public sector financial year (1st April 2025 – 31st March 2026).

(A3) Does your organisation undertake Adult ADHD Assessments? If yes, please list:
(A3-i) the organisation or organisations that have contracted you to provide the ADHD Assessment service alongside the financial contract value for the last public sector financial year (1st April 2024 – 31st March 2025) and the current public sector financial year (1st April 2025 – 31st March 2026).

(A4) Does your organisation undertake Child ADHD Assessments? If yes, please list:
(A4-i) the organisation or organisations that have contracted you to provide the ADHD Assessment service alongside the financial contract value for the last public sector financial year (1st April 2024 – 31st March 2025) and the current public sector financial year (1st April 2025 – 31st March 2026).

Section B

Please could you provide the information for the last public sector year (the period covering 1st April 2024 – 31st March 2025).

(B1). The number of Adult ADHD Assessments undertaken in that period
(B2). The number of Adults waiting for an ADHD Assessment at the end of that period.
(B3). The number of Adults waiting for an ADHD Assessment at the date of receipt of this FOI request.
(B4). The number of Child ADHD Assessments undertaken in that period
(B5). The number of Children waiting for an ADHD Assessment at the end of that period.
(B6). The number of Children waiting for an ADHD Assessment as of the date of receipt of this FOI request.

If it does not take us over the FOI cost threshold, then please can we ask similar questions for the prior public sector year. For the period covering 1st April 2023 to 31st March 2024.

(B7). The number of Adult ADHD Assessments undertaken in that period
(B8). The number of Adults waiting for an ADHD Assessment at the end of that period.
(B9). The number of Child ADHD Assessments undertaken in that period
(B10). The number of Children waiting for an ADHD Assessment in that period.

If it does not take us over the FOI cost threshold, then please can we ask the same questions for the public sector, the year before the above. For the period covering 1st April 2022 to 31st March 2023.

(B11). The number of Adult ADHD Assessments undertaken in that period
(B12). The number of Adults waiting for an ADHD Assessment at the end of that period.
(B13). The number of Child ADHD Assessments undertaken in that period
(B14). The number of Children waiting for an ADHD Assessment in that period.

If it does not take us over the FOI cost threshold, then please can we ask the same questions for the public sector, the year before the above. For the period covering 1st April 2021 to 31st March 2022.

(B15). The number of Adult ADHD Assessments undertaken in that period
(B16). The number of Adults waiting for an ADHD Assessment at the end of that period.
(B17). The number of Child ADHD Assessments undertaken in that period
(B18). The number of Children waiting for an ADHD Assessment in that period.

Section C

If it does not take us over the FOI cost threshold, then please can we ask this additional set of questions

(C1). Did you pay out under Right to Choose for Adult ADHD Assessments in the prior public sector year? If yes:

(C1-i) How many Adult ADHD Assessments were paid out under Right to Choose in the last public sector year (20024-25)
(C2-ii) What was the total value of Adult ADHD Assessments under Right to Choose in the last public sector year (20024-25).
(C2-iii) Please list the organisations you paid out for Adult ADHD Assessments under Right to Choose, alongside the total financial amount paid, and the quantity of Adult ADHD Assessments undertaken for the last public sector year (April 1st 2024- 31st March 2025).

(C2). Did you pay out under Right to Choose for Child ADHD Assessments in the prior public sector year? If yes:

(C1-i) How many Child ADHD Assessments were paid out under Right to Choose in the last public sector year (20024-25)
(C2-ii) What was the total value of Child ADHD Assessments under Right to Choose in the last public sector year (20024-25).
(C2-iii) Please list the organisations you paid out for Child ADHD Assessments under Right to Choose, alongside the total financial amount paid, and the quantity of Child ADHD Assessments undertaken for the last public sector year (April 1st 2024- 31st March 2025).

Please can you provide me with the below information:

In the last 6 months, please confirm if any Mental Health services have been outsourced:

If yes, please confirm:

-The service provided E.G ADHD, Autism etc (please provide breakdown for each service if applicable)
-The name of the company each service was outsourced to
-Is there a contract in place and the length of contract for each service provided (if applicable)
-The value of each service in the last 6 months

Please provide an email and contact name within the outsource provider

I am writing to request information under the Freedom of Information Act 2000 regarding funding requests for external assessments and/or treatment of dissociative disorders (including DID, OSDD, DPDR, etc.) made via the Specialist Treatment and Rehabilitation Team (STAR).

Please provide the following information covering the period from 1st January 2020 to the present:

1. How many requests have been received by the STAR team for funding of assessment and/or treatment for dissociative disorders with external providers (e.g. Centre for Dissociative Studies, Pottergate Centre, CTAD, SLAM, etc)?

2. Of these requests, how many were approved for funding?

3. What is the typical cost of:
a. An initial assessment at these external providers.
b. A course of treatment (e.g. per session, per year, or other available metric).

4. Are there any planned changes to how the STAR team manages referrals or funding for dissociative disorder care (e.g. new internal pathways, new commissioning plans, or external contracting)?

This is a request for the following data:

– How many ADHD patients do you have currently?
– What percentage of ADHD patients are prescribed stimulant medication?
– How many ADHD patients have stopped taking stimulant medication since 2020? Please specify how many patients stopped because of side effects they were experiencing and make a brief note of the side effect
– Since 2020 how many ADHD patients were prescribed non-pharmacological treatment? This could include Cognitive Behavioral Therapy, parent of family training, neurofeedback or advice and programs related to mindfulness and yoga. Please specify what the treatment was.

I am writing to request the following information under the Freedom of Information Act 2000.

Please provide data for the period April 2024 to March 2025, broken down by calendar month where applicable as well as planned capital works for the current year 2025/2026. The following request: 1. People in Beds a. Acute Mental Health Placements (Out-of-Trust / Private Sector) • The number of female patients placed in private sector or out-of-trust acute mental health beds each month. • The number of male patients placed in private sector or out-of-trust acute mental health beds each month. b. PICU (Psychiatric Intensive Care Unit) Placements (Out-of-Trust / Private Sector) • The number of female patients placed in private sector or out-of-trust PICU beds each month. • The number of male patients placed in private sector or out-of-trust PICU beds each month. c. Rehabilitation Mental Health Placements • The number of patients placed in rehabilitation mental health placements, broken down by gender (male/female) and by month. 2. Bed Day Costs For the period April 2024 to March 2025, please provide the average daily bed fee paid for private sector placements, broken down by patient gender (if available) and setting: • Acute mental health placements • PICU placements • Rehabilitation placements 3. Placement Locations Please provide the names and addresses (or town/city) of all private sector or out-of-trust facilities where patients (both male and female) were placed in the following settings: • Acute mental health • PICU • Rehabilitation 4. Clinically Ready for Discharge (CRFD) Please provide the number of patients occupying NHS Trust acute mental health beds each month who were deemed clinically ready for discharge but remained in hospital (commonly referred to as Delayed Transfers of Care – DTOC). 5. Planned Capital Improvement Works Please confirm whether there are any planned or ongoing capital improvement works during the period April 2025 – March 2026 that may impact patient flow (e.g. reduction in bed availability, ward closures, reconfigurations). If so, please provide a summary of the works, broken down by service area: • Acute (Adult and Older Adult) • CAMHS (Child and Adolescent Mental Health Services) • Forensic Services • Specialist Services (e.g. Perinatal, Eating Disorders, Neuropsychiatry) T

I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).

The information being requested is as follows:

1. Please provide the number of ECT treatments given to patients for each of the calendar years 2023 & 2024.

2. Please provide the number of people who received the ECT in each of the calendar years 2023 and 2024.

I’d like to request whether you hold any SOPs for the management of Restrictive Intake Self-Harm (RISH) or restricted food in the context of eating disorders or similarly titled SOPS in either your general or acute hospitals.

CAMHS liaison service in Portsmouth (Queen Alexandra Hospital) are hoping to review existing literature to support general hospital colleagues to construct a SOP for supporting this patient group in general hospitals.

The Specialist Treatment and Recovery (STAR) team is a team commissioned by GICB to provide assistance with complex mental health needs that cannot be met by existing commissioned services.

Firstly can you provide all information you have regarding the responsibility, duties and aims of the STAR team? Are they a subsection of the recovery team? What facilities, treatments and resources do they have access to? Are they supposed to interact with patients directly or do they possess a more bureaucratic role or do the members provide treatment themselves?

Secondly can you provide a contact email address for the STAR team.

I am writing to you on behalf of Alzheimer’s Research UK (Registered charity number 1077089) under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health & Care NHS Foundation Trust.

Please can you provide us with the following:

A. The number of memory assessment services that you operate.

B. The area covered by each of these memory assessment services.

For each individual memory assessment service you operate:

1. The service’s annual funding for each of the years 2018-2024 inclusive.

2. The source/s of funding for the service for each of the years 2018-2024 inclusive.

3. The total annual number of patients seen by the service for each of the years 2018-2024 inclusive.

I would like to determine the number of NHS Mental Health Trusts that offer Animal Assisted Therapy to their patients.

I would also like to know how much is spent by the Mental Health Trusts on Animal Assisted Therapies each year.

Finally I would like to know who conducts the animal assisted interventions, is it NHS clinicians or teams brought in specifically to conduct the intervention.

1. Please identify the Talking Therapies service that you are answering on behalf of.
2. Please may you inform us whether Body Dysmorphic Disorder (BDD) appears on your drop-down menu as a diagnosis/ problem descriptor on for example
IAPTus or PC-MIS software for measuring outcomes? (If not, what descriptor, do you use?)
3. If it is not on the drop-down menu, can you identify people with BDD in a different way (for example, the number who have completed the Body Image Questionnaire for BDD)?  
4. Do you use a digital front door like Limbic to screen clients? If yes, which one do you use, and does it directly screen for BDD?
5. Please inform us whether your staff ask the recommended screening question to help identify people with BDD? (The “Talking Therapies manual for anxiety and depression” recommends a question “Have you worried a lot about your appearance or the way a bodily feature looked and wish you could think about it less?”. ) If you do not use the recommended question, do you routinely screen for BDD with a different question or leave it up to therapists to identify if it appears clinically relevant? (if yes, what is the question)?
6. If you use a screening question to try to identify people with BDD, at what stage do you ask the question. e.g., (a) first contact/triage, (b) at assessment at step 2 guided self-help (c) at assessment for step 3 (high intensity)?
7. Please inform us if you use the recommended Anxiety Disorder Specific Measure (ADSM) “The Body Image Questionnaire” (BIQ) in people with BDD to determine outcomes during therapy?  If not, do you use the PHQ9 and GAD7 for BDD or something else?
8. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the total number of people you discharged (all diagnoses, at least one contact) and the total number of people discharged for BDD as the main problem.
9. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the total number of people you took on for therapy (all diagnoses, at least 2 contacts) and the total number of people with BDD that you took on for therapy (at least 2 contacts) that were discharged.
10. Of those that you took on for therapy, what proportion / numbers of people with BDD received treatment at Step 2 with a PWP? If treatment is with a PWP, what proportion and number is a generic CBT for anxiety/ depression or other approach, and what proportion and number received a specific computer program or workbook for BDD?  Please specify which one you use.
11. Of those with BDD who received treatment at Step 2 with a PWP, what was the average number of sessions for generic CBT for anxiety/ depression and for a specific computer program or workbook for BDD?
12. For people discharged from the 1st April 2023 to 31st March 2024 with the last treatment type being step 3, what was the average number of sessions in the episode for those treated with BDD and the average for all other diagnoses in the service?
13. For people discharged in the year 1st April 2023 – 31st March 2024, please inform us of the number of people with BDD who had 2 Body Image Questionnaires completed prior to discharge (and the number who had the GAD7 instead of the BIQ) at Step 2 and at Step 3 (high intensity)?
14. For people discharged in the year 1st April 2023 – 31st March 2024, what percentage and number of people with BDD in the treated sample achieve reliable improvement at Step 2 and Step 3? (Note the reliable change on the BIQ is ≥10 – please state if you are using the GAD7 for reliable improvement). How does that compare to the percentage and number who achieve reliable improvement on all the other diagnoses in the service?
15. For people discharged in the year 1st April 2023 – 31st March 2024, what was the mean and standard deviation and number of clients of the Body Image Questionnaire in those taken on for treatment at Step 2 and at Step 3?
16. For people discharged in the year 1st April 2023 – 31st March 2024, what was the mean and standard deviation and number of clients with BDD on the Body Image Questionnaire after treatment at Step 2 and at Step 3?
17. For people discharged in the year 1st April 2023 – 31st March 2024, what proportion and number achieve reliable improvement and recovery after treatment (≤ 40 is no longer a case) with BDD on the Body Image Questionnaire at Step 2 and Step 3?
18. How many of your CBT therapists have attended a top up workshop or any other training in treating BDD?
19. Please can you do a survey of your CBT therapists in your service and ask them.  
“How much of a priority do you think is training in BDD compared to other problems in your service?”
1. – Not a priority 
2. – Low priority 
3. – Medium priority
4. – High priority
5. – Essential 

1 (a) In the last 12 months (of data), in total how many patients with Schizophrenia and other non-mood disorders (F20-F29 inclusive) were managed by your Trust.
1 (b) In the last 12 months (of data), in total how many patients diagnosed Schizophrenia (F20 only) were managed by your Trust.

2 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders have been treated within each of the following services:
• Early Intervention Psychosis service team
• Community Mental Health Team

2 (b) In the last 3 months (of data), how many patients with Schizophrenia had no change to the antipsychotic medication within each of the following services. This includes patients with no change in dose.
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged to primary care from each of the following services?
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (b) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged from the Early Intervention Psychosis service team to the Community Mental Health Team

1. The number of individuals who have received support or counselling related to fireworks (e.g., anxiety, trauma, or phobias triggered by fireworks).

2. The data categorised by:
1. Age
2. Gender
3. Year (2021, 2022, 2023, and 2024).
4. Month
5. If possible, broken down by condition:
i. Anxiety, Trauma, Depression, PTSD, Phobia, Ligyrophobia (also spelled Ligurophobia or Phonophobia).

Freedom of Information Request – Ref: 184-2024 Thank you for your recent Freedom of Information...